If you remember headlines about angel dust and crack, you know that drug panics are nothing new. From time to time an intoxicating drug is rediscovered or newly synthesized, or old ones are consumed in new ways, leading to public fascination and forecasts of doom. We’ve seen that recently with widespread attention paid to fentanyl and tranq, and a recent article in The New York Times about “super meth” and “polysubstance use.”
The November 13 Times piece headlined “‘A Monster’: Super Meth and Other Drugs Push Crisis Beyond Opioids” consists of a high panic to substance ratio. As Reason‘s Jacob Sullum pointed out, “super meth” is not new, but represents a return to making methamphetamine from phenyl-2-propanone (P2P) the way the Hell’s Angels did in the past before illicit manufacturers started deriving it from pseudoephedrine. Now that allergy medications containing pseudoephedrine are strictly controlled, underground labs have returned to old techniques.
Well, of course. Black market operators always innovate to work around laws and law enforcers.
The rest of the of the article, on the simultaneous consumption of several drugs, is equally unremarkable, though outcomes remain as unfortunate as ever.
Hellbound and Down 